➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Mallinckrodt
McKesson
AstraZeneca
Johnson and Johnson

Last Updated: May 18, 2021

DrugPatentWatch Database Preview

Bel Mar Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BEL MAR, and what generic and branded alternatives to BEL MAR drugs are available?

BEL MAR has twenty-five approved drugs.



Summary for Bel Mar
US Patents:0
Tradenames:17
Ingredients:16
NDAs:25

Drugs and US Patents for Bel Mar

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar PREDNISOLONE ACETATE prednisolone acetate INJECTABLE;INJECTION 083738-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Bel Mar VITAMIN A PALMITATE vitamin a palmitate INJECTABLE;INJECTION 080819-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Bel Mar TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080741-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Bel Mar LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080757-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Bel Mar LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080760-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Bel Mar PROCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; procaine hydrochloride INJECTABLE;INJECTION 080759-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
McKinsey
Moodys
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.